Sharon Klugewicz Joins Bioventus as Senior Vice President, Quality and Regulatory Affairs
November 01, 2021 08:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has appointed Sharon Klugewicz as...
Bioventus Completes the Acquisition of Misonix
October 29, 2021 08:25 ET
|
Bioventus, Inc.
DURHAM, N.C., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed the acquisition of...
Bioventus to Release Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021
October 27, 2021 16:15 ET
|
Bioventus, Inc.
DURHAM, N.C., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that third quarter of...
Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus
October 26, 2021 16:15 ET
|
Bioventus, Inc.
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, and Misonix,...
BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration
October 18, 2021 08:00 ET
|
Bioventus, Inc.
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), today announced an election deadline of 5:00 p.m.,...
DUROLANE® Among High-Molecular Weight Hyaluronic Acid Treatments Linked to Significant Improvements in Knee Osteoarthritis Pain by American Academy of Orthopaedic Surgeons
September 20, 2021 08:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc., (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in innovations for active healing, announced that the American Academy of...
Bioventus Proceeds with Option Structure Agreement with CartiHeal
August 30, 2021 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has elected to make a $50 million...
Bioventus Invests in Trice Medical Minimally Invasive Technologies
August 25, 2021 16:05 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed a strategic investment...
Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer
August 23, 2021 08:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has appointed Dave Crawford as its...
Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance
August 10, 2021 16:05 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...